SCHEMBL3458220

SCHEMBL3458220

CCN1C=CN(c2ccccc2)C1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 2/20 0.36
ELANE P08246 4/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
MAOA P21397 1/20 0.33
ATM Q13315 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MAPK1 P28482 1/20 0.32
GSK3B P49841 2/20 0.32
GSK3A P49840 1/20 0.32
DRD2 P14416 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
ALOX5 P09917 1/20 0.30
GAA P10253 1/20 0.30
G6PD P11413 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16730238 1.00 CHRNA7 (0.36) CHRNA7ELANEKDM4EALDH1A1MAPT
SCHEMBL16711466 0.86 MAOA (0.34) ELANEMAOAMAPK1GAAG6PD
SCHEMBL5285912 0.85 DRD2 (0.40) CHRNA7ELANEMAPTKMT2AMAOA
SCHEMBL5302977 0.82 RAB9A (0.38) ELANEKDM4EALDH1A1MAPTHPGD
SCHEMBL5290363 0.81 KCNH2 (0.36) ELANEKDM4EALDH1A1MAPTKMT2A
SCHEMBL12170156 0.81 MAOA (0.41) CHRNA7ELANEKDM4EALDH1A1MAPT
SCHEMBL5325309 0.80 KCNH2 (0.38) ELANEKDM4EALDH1A1MAPTKMT2A
SCHEMBL5293155 0.80 KCNH2 (0.38) ELANEKDM4EALDH1A1MAPTKMT2A
SCHEMBL5293812 0.80 KCNH2 (0.38) ELANEKDM4EALDH1A1MAPTKMT2A
SCHEMBL5298019 0.80 KCNH2 (0.38) ELANEKDM4EALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100321863-A1 ACTIVATED CARBON AND PROCESS FOR PRODUCING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-12-23 US disclosed
US-7785495-B2 Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-08-31 US disclosed
CN-101535179-A Activated carbon and method for producing the same SUMITOMO CHEMICAL CO (JP) 2009-09-16 CN disclosed
EP-2093191-A1 ACTIVATED CARBON AND METHOD FOR PRODUCING THE SAME Sumitomo Chemical Company, Limited (JP) 2009-08-26 EP disclosed
US-20090103241-A1 Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-04-23 US disclosed
CN-101184691-A Electric double layer capacitor SUMITOMO CHEMICAL CO (JP) 2008-05-21 CN disclosed
EP-1905740-A1 ELECTRIC DOUBLE LAYER CAPACITOR Sumitomo Chemical Company, Limited (JP) 2008-04-02 EP disclosed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO disclosed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090103241-A1 Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 CBR1, CYP24A1, CALU CHRNA7 1263/4885ELANE 306/4885KDM4E 2457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.